2seventy bio, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ASND
Ascendis Pharma A/S |
$137.53 | $7.77 B | -14.19 | 879 | $266.72 M |
CGEM
Cullinan Oncology, Inc. |
$12.03 | $1.29 B | -7.16 | 85 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$51.87 | $3.53 B | -11.86 | 290 | $4.01 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.87 | $1.12 B | -5.11 | 174 | $0 |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
ICPT
Intercept Pharmaceuticals, Inc. |
$19.00 | $794.69 M | -17.43 | 341 | $285.71 M |
INZY
Inozyme Pharma, Inc. |
$2.91 | $286.39 M | -3.43 | 59 | $0 |
IOVA
Iovance Biotherapeutics, Inc. |
$7.38 | $2.18 B | -4.3 | 557 | $1.19 M |
KDNY
Chinook Therapeutics, Inc. |
$40.39 | $2.71 B | -12.47 | 214 | $6.13 M |
KZR
Kezar Life Sciences, Inc. |
$6.64 | $49.85 M | -0.49 | 58 | $7.00 M |
MRSN
Mersana Therapeutics, Inc. |
$1.51 | $261.85 M | -1.91 | 123 | $36.86 M |
PBYI
Puma Biotechnology, Inc. |
$3.07 | $170.04 M | 11.02 | 185 | $235.64 M |
PHAT
Phathom Pharmaceuticals, Inc. |
$8.18 | $620.47 M | -2.38 | 452 | $682,000 |
PLRX
Pliant Therapeutics, Inc. |
$13.58 | $672.63 M | -3.9 | 166 | $1.58 M |
PTGX
Protagonist Therapeutics, Inc. |
$38.94 | $2.04 B | 13.7 | 126 | $60.00 M |
RCUS
Arcus Biosciences, Inc. |
$15.27 | $1.41 B | -4.98 | 577 | $117.00 M |
REPL
Replimune Group, Inc. |
$12.25 | $485.18 M | -2.44 | 331 | $0 |
RLAY
Relay Therapeutics, Inc. |
$4.37 | $1.05 B | -3 | 294 | $25.55 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$12.80 | $1.66 B | -6.02 | 184 | $0 |
SRPT
Sarepta Therapeutics, Inc. |
$121.57 | $11.66 B | 286.79 | 1314 | $1.24 B |
STOK
Stoke Therapeutics, Inc. |
$11.05 | $774.50 M | -6.14 | 110 | $8.78 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.06 | $754.16 M | -3.26 | 124 | $0 |